Echo Therapeutics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenues of $19,107 against $22,557 a year ago. Loss from operations was $3,915,482 against $6,094,939 a year ago. Net loss was $3,763,976 or $0.31 per basic and diluted share against $3,341,397 or $0.51 per basic and diluted share a year ago.

For the six months, the company reported total revenues of $38,214 against $45,114 a year ago. Loss from operations was $6,585,183 against $11,591,552 a year ago. Net loss was $6,537,017 or $0.55 per basic and diluted share against $10,329,722 or $1.73 per basic and diluted share a year ago.